We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Decoding Human Genes the Goal of New Open-Source Encyclopedia

By LabMedica International staff writers
Posted on 11 May 2011
A massive database cataloging the human genome's functional elements--including genes, RNA transcripts, and other products--is being made available as an open resource to the scientific community, science writers, classrooms, and the public, due to the work of an international team of researchers. More...


In an article published in the journal PLoS Biology on April 19, 2011, the project--called ENCODE (Encyclopedia Of DNA Elements)--provides an overview of the team's ongoing efforts to interpret the human genome sequence, as well as a guide for using the vast amounts of data and resources produced so far by the project.

Ross Hardison, a professor of biochemistry and molecular biology at Pennsylvania State University (Penn State; University Park, PA, USA) and one of the lead investigators of the ENCODE Project team, explained that the philosophy behind the project is one of scientific openness, transparency, and collaboration across subdisciplines. ENCODE comes on the heels of the now-complete Human Genome Project--a 13-year effort aimed at identifying all the approximately 20,000 to 25,000 genes in human DNA--which also was based on the belief in open-source data-sharing to further scientific discovery and public understanding of science. The ENCODE Project has accomplished this goal by publishing its database online, and by posting tools to facilitate data use (please see Related Links below).

Dr. Hardison noted there are about 3 billion base pairs in the human genome, making the cataloging and interpretation of the information a colossal task. "We have a very lofty goal: To identify the function of every nucleotide of the human genome,” he said. "Not only are we discovering the genes that give information to cells and make proteins, but we also want to know what determines that the proteins are made in the right cells, and at the appropriate time. Finding the DNA elements that govern this regulated expression of genes is a major goal of ENCODE.”

ENCODE's task is to identify the human genome's functional regions, many of which are quite esoteric, according to Dr. Hardison. Dr. Hardison stated that the ENCODE Project supplies data such as where proteins bind to DNA and where parts of DNA are augmented by additional chemical markers. These proteins and chemical additions are keys to determining how different cells within the human body interpret the language of DNA.

In the article, the scientists reveled how the ENCODE data can be immediately useful in interpreting associations between disease and DNA sequences that can vary from individual to individual--single nucleotide polymorphisms (SNPs). For example, scientists know that DNA variants located upstream of a gene called MYC are associated with multiple cancers, but until recently the mechanism behind this association was a mystery. ENCODE data already have been utilized to confirm that the variants can change binding of specific proteins, leading to enhanced expression of the MYC gene, and therefore, to the development of cancer. ENCODE also has made similar studies possible for thousands of other DNA variants that may be associated with susceptibility to a variety of human diseases.

Another of the principal investigators of the project, Dr. Richard Myers, president and director of the HudsonAlpha Institute for Biotechnology (Huntsville, AL, USA), explained that the ENCODE Project is unique because it requires collaboration from multiple people all over the world at the cutting edge of their fields.

Scientists with the ENCODE Project also are applying up to 20 different tests in 108 commonly used cell lines to compile important data. John Stamatoyannopoulos, an assistant professor of genome sciences and medicine at the University of Washington (Seattle, USA) and another lead investigator, reported that the ENCODE Project has been responsible for producing many assays--molecular-biology procedures for measuring the activity of biochemical agents--that now are fundamental to biology. "Widely used computational tools for processing and interpreting large-scale functional genomic data also have been developed by the project,” Prof. Stamatoyannopoulos said. "The depth, quality, and diversity of the ENCODE data are unprecedented.”

Dr. Hardison noted that the portion of the human genome that actually codes for protein is approximately 1.1%. "That's still a lot of data,” he said, "and to complicate matters even more, most mechanisms for gene expression and regulation lie outside what we call the ‘coding' region of DNA.”

Dr. Hardison explained that scientists have a limited number of tools with which to explore the genome, and one that has been used widely is inter-species comparison. "For example, we can compare humans and chimpanzees and glean some fascinating information,” he concluded, "but very few proteins and other DNA products differ in any fundamental way between humans and chimps. The important difference between us and our close cousins lies in gene expression--the basic level at which genes give rise to traits such as eye color, height, and susceptibility to a particular disease. ENCODE is helping to map the very proteins involved in gene regulation and gene expression. Our paper not only explains how to find the data, but it also explains how to apply the data to interpret the human genome.”

The ENCODE Project is funded, primarily, by the National Human Genome Research Institute of the US National Institutes of Health (Bethesda, MD, USA).

Related Links:
ENCODE Database

Pennsylvania State University



Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Parainfluenza Virus Test
PARAINFLUENZA ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.